Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
GLP-1 microdosing, based on current evidence, functions as a complementary approach, not a substitute for standard immunotherapies
The comparability of patient characteristics between two study groups was achieved by the three-step matching on (1) the index date, (2) prior exposure to GLAs in the year before the index date, and (3) patient demographic and clinical characteristics (e.g., diabetes severity, comorbidities, co-medications for cardiovascular diseases [CVDs]) using the propensity score matching approach [6]
6X18: Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, enel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D
I., Brett, E
When NT is injected into the NAc, it reduces the response to psychostimulants (Ervin et al., 1981
Newman, H., Catt, S., Vining, B., Vollenhoven, B
US$ 20.80
US$ 26.14
US$ 22.68
